These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 73489)

  • 21. In vivo and in vitro cell-mediated immune reactions to auto-chthonous tumor extracts in patients with gastric cancer.
    Nakajima T; Gonmori M; Isojima K; Iwaguchi T
    Gan; 1976 Aug; 67(4):537-47. PubMed ID: 1024851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on immunospecificity of skin test using tumor extract in gynecological malignancy (author's transl)].
    Yuzawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):611-8. PubMed ID: 6165790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Improvement of specificity and reactivity of the leukocyte migration test for the diagnosis and follow-up care in stomach cancer].
    Schulz U; Zoeller M; Matzku S
    Chir Forum Exp Klin Forsch; 1977 Apr; ():63-8. PubMed ID: 618315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demonstration of cellular immunity in chronic myeloid leukaemia using leucocyte migration inhibition assay.
    Gangal SG; Gothoskar BP; Joshi CS; Advani SH
    Br J Cancer; 1976 Mar; 33(3):267-72. PubMed ID: 1063589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survivability and leucocyte migration inhibition in mice immunized with cryotreated ascites fibrosarcoma cells using different freeze-thaw cycles.
    Roy A; Lahiri S; Lahiri P; Pal S; Ghosh S; Roy B
    Indian J Exp Biol; 1995 Jul; 33(7):485-8. PubMed ID: 7590956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formalinized tumour cells in the leucocyte migration inhibition test.
    Ross CE; Cochran AJ; Hoyle DE; Grant RM; Mackie RM
    Clin Exp Immunol; 1975 Oct; 22(1):126-32. PubMed ID: 1212813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specificity of micro-leucocyte adherence inhibition test in patients with gastric cancer.
    Koide Y; Wakazono K; Yamagata K; Miyaji M; Yamamoto M
    Gan; 1979 Aug; 70(4):541-4. PubMed ID: 92433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Isolation of soluble tumor-associated antigens of human malignant melanoma].
    Suter L
    Fortschr Med; 1978 Aug; 96(32):1615-8. PubMed ID: 680624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukocyte migration inhibition in vitro in bladder carcinoma.
    Lavergne JA; Lamm DL; Radwin HM; Harrington JT
    Cancer Res; 1979 Jun; 39(6 Pt 1):1985-8. PubMed ID: 445398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [KCl-tumor extracts in the electrophoretic mobility test [EMT]. - Clinical relevance to diagnosis of gastric cancer (author's transl)].
    Muhrer KH; Schwemmle K; Stambolis C; Kahle M
    Z Gastroenterol; 1982 Jul; 20(7):376-83. PubMed ID: 7113315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro migration inhibition of leukocytes from cancer patients by extracts of autologous and homologous tumors].
    Novikov DK; Adamenko GP
    Dokl Akad Nauk SSSR; 1974; 217(3):715-8. PubMed ID: 4848926
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma.
    McCoy JL; Jerome LF; Dean JH; Perlin E; Oldham RK; Char DH; Cohen MH; Felix EL; Herberman RB
    J Natl Cancer Inst; 1975 Jul; 55(1):19-23. PubMed ID: 1057654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of cellular immune response to cancer of the breast.
    Herberman RB
    Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue.
    Paque RE; Gauntt CJ; Nealon TJ; Trousdale MD
    J Immunol; 1978 May; 120(5):1672-8. PubMed ID: 207775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KCl carcinoma extracts as tumor antigens in the electrophoretic mobility test: clinical evaluation.
    Muhrer KH; Link KH
    Cancer Detect Prev; 1983; 6(1-2):101-6. PubMed ID: 6883371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanisms of the potentiating and blocking effects of the sera from tumor patients in the leukocyte migration inhibition reaction model].
    Grigor'eva MP
    Vopr Onkol; 1979; 25(1):31-8. PubMed ID: 85367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between lymphocyte proliferation and migration inhibitory factor production in response to autologous tumor extract in cancer patients.
    Akiyoshi T; Miyazaki S; Koba F; Kawaguchi M; Tsuji H
    Gan; 1981 Dec; 72(6):988-91. PubMed ID: 6210594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukocyte migration inhibition response to various antigen preparations of autologous and homologous breast cancer in patients with primary breast cancer.
    Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH
    J Natl Cancer Inst; 1979 Nov; 63(5):1161-9. PubMed ID: 91696
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of tumor antigens on leukocyte adherence in the blood in stomach cancer].
    Zharkov VV; Novikov DK
    Vopr Onkol; 1983; 29(2):14-8. PubMed ID: 6836968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of leukocyte migration by human breast-cancer-associated antigens.
    Kadish AS; Marcus DM; Bloom BR
    Int J Cancer; 1976 Nov; 18(5):581-6. PubMed ID: 62721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.